Mayo’s plasma program shows first signs of COVID-19 benefit
![](https://www.hennepinhealthcare.org/wp-content/plugins/bb-plugin/img/pixel.png)
“We’re all kind of waiting for more standard products to come out where you know how much antibody that someone is getting,” said Dr. Anne Frosch, who is leading HCMC’s COVID-19 convalescent plasma program.